Metraipolis › archive › dc_3b41da84dd39

Circulating miR-221/222 and Serum IL-23 in Treatment-Naïve Multiple Sclerosis: A Case-Control Study — Europe PMC PMID:42654365

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42654365
DOI
10.3390/medicina62081468
License (as archived)
solo-consultazione
Archived
2026-10-17T09:48:53.223Z
SHA-256 of the archived text
20cea009dc4a9c15edcbd76dff06e5678810a61f1bf8f57738446977549095a1
Stable URL of this page
https://metraipolis.com/documento/dc_3b41da84dd39

How to cite

Circulating miR-221/222 and Serum IL-23 in Treatment-Naïve Multiple Sclerosis: A Case-Control Study — Europe PMC PMID:42654365 — Europe PMC (en), https://europepmc.org/article/MED/42654365 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3b41da84dd39 (Metraipolis archive dc_3b41da84dd39, sha256 20cea009dc4a9c15edcbd76dff06e5678810a61f1bf8f57738446977549095a1)
BibTeX
@misc{dc3b41da84dd39,
  title = {Circulating miR-221/222 and Serum IL-23 in Treatment-Naïve Multiple Sclerosis: A Case-Control Study — Europe PMC PMID:42654365},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42654365},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3b41da84dd39; sha256 20cea009dc4a9c15edcbd76dff06e5678810a61f1bf8f57738446977549095a1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42654365. Agents can read the archived copy with the MCP tool read_document.